U.S. flag An official website of the United States government
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. Airborne Respiratory Viral Infections and Non-Pharmaceutical Interventions - 06/14/2022
  1. Advancing Regulatory Science

Webcast | Virtual

Event Title
Airborne Respiratory Viral Infections and Non-Pharmaceutical Interventions
June 14, 2022

June 14, 2022

University Of Maryland CERSI

Presented By

Donald K. Milton, MD, DrPH

Donald K. Milton, MD, DrPH
Professor of Environmental and Occupational Health
University of Maryland School of Public Health

About the Presentation

Multiple lines of evidence point to inhalation of viral aerosols as a major driver of the COVID-19 pandemic rekindling interest in understanding airborne transmission of respiratory infections. This talk reviewed the aerobiological pathway of infection transmission focusing on SARS-CoV-2 and influenza. We discussed aerosol generation and deposition in the human respiratory tract and the impact of non-pharmaceutical interventions, key knowledge gaps and research needs.

About the Presenter

Donald K. Milton, MD, DrPH, is a Professor of Environmental Health at the University of Maryland School of Public Health, with a secondary appointment in the University of Maryland School of Medicine’s Department of Medicine. An internationally recognized expert on the aerobiology of respiratory viruses, Dr. Milton developed the concept of using indoor CO2 to directly measure rebreathed air and airborne infection risk. He is the Principal Investigator of the UMD StopCOVID study (investigating SARS-CoV-2 transmission) and of the newly NIH-funded Evaluating Modes of Influenza Transmission (EMIT-2) study, a 5-year $15 million UMD-UMB collaboration to perform randomized controlled trials that will define the modes and mechanisms of influenza transmission. Dr. Milton graduated from University of Maryland, Baltimore County with a Bachelor of Arts in Chemistry in 1976 and obtained his Doctor of Medicine from Johns Hopkins University in 1980. He went on to obtain his Master of Occupational Health and Doctor of Public Health from the Harvard School of Public Health in 1985 and 1989, respectively.



Play recording (58 mins)

For Questions and Reasonable Accommodations:

Please contact LaToya Richardson at Latoya.Richardson@fda.hhs.gov.


Back to Top